Calcium metabolism

About 100 million people worldwide suffer from degenerative joint disease and presumably its incidence will further increase due to demographic and lifestyle changes. The loss of articular cartilage during joint destruction is irreversible and current therapies are unsuitable to stop or even reverse cartilage loss.

Thus, it is of special importance to diagnose degenerative joint diseases as early as possible and to start an appropriate therapy before the disease has become radiologically apparent.

With the measurement of biomarkers, degenerative joint diseases can be a) detected already in the initial stage, b) monitored or c) even predicted.

Cat-No.	Productname
K2109	25-OH-Vitamin D direct
60-4000	Anti-human PTH 1-34 Antibody
7024	Calcitonin, Human
50-5000	Calcitonin, Rat
60-6100	FGF-23 (C-Term) 2nd Generation
60-6300	FGF-23 (C-Term) Mouse
60-6500	FGF-23 Intact, Human
CY-4000	FGF-23 Intact, Human (Kainos)
KT-800	Human Fetuin-A
JP27998	Klotho, Human
60-3900	PTH 1-34 Human, high sensitive
60-3000	PTH 1-84 Bioactive, Human
60-2700	PTH 1-84 Bioactive, Rat
60-3800	PTH 1-84 Intact, Dog
7022	PTH 1-84 Intact, Human
60-2305	PTH 1-84 Intact, Mouse
60-2500	PTH 1-84 Intact, Rat
60-3500	PTH 1-84, Bovine
60-3305	PTH 1-84, Porcine
60-3200	PTH C-Terminal, Human
60-2200	PTH C-Terminal, Rat
60-3100	PTH, Horse
50-2000	PTH, Rat

Back to overview